-
Document de presse | 2022.10.21
SpikImm announces the clinical trials start for SPK001, its monoclonal antibody against SARS-CoV-2
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the...
-
Document de presse | 2022.10.30
Institut Pasteur Welcomes New, Comprehensive Relationship With UCSF QBI
Two Academic and Scientific Heavyweights Agree to Implement Joint Actions Towards the Creation of a Center of Excellence in Emerging Infectious Diseases with Planned Operations/Locations in Paris and San Francisco. In a ceremony on October 21, 2022, the Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI) announced a new partnership for the joint establishment...
-
Article | 2022.11.10
Diversity, Equity, and Inclusion (DEI) Commitment
We are proud to state that diversity is our greatest asset in our fight for human health. “Science knows no country, because knowledge belongs to humanity”, as Louis Pasteur said.
-
News | 2022.10.21
New progress on the genetic factors involved in dyslexia
Three studies conducted by an international consortium, published in the journals Molecular Psychiatry, PNAS and Nature Genetics, have revealed several dozens of genes associated with dyslexia and reading skills. These analyses, performed on a large number of participants, have enabled scientists to detect the first genetic variations associated with dyslexia and reading skills in genes involved...
-
News | 2022.10.27
Hospital-acquired infections: a key molecule that helps Clostridium difficile adapt to the gut environment
Hospital-acquired infections caused by Clostridioides difficile represent a major health threat. In a recently published study, scientists describe the molecular mechanisms that enable the bacteria to survive, adapt and develop in the gut. They demonstrate that the c-di-AMP molecule plays a central role in C. difficile's internal regulation mechanisms, promoting antimicrobial resistance.
-
Événement | 2022.12.02
Epidemic, pandemic... Infodemic: the other health emergency
The symposium called "Epidemic, pandemic... Infodemic: the other health emergency", organized by Université Paris Cité and the Institut Pasteur, will be held on December 2, 2022. This event will take place at the Institut Pasteur (Paris, 15th arrondissement), in French. Registration is free but mandatory.(This event will be held in French)Les questions de communication et d’information...
-
News | 2022.11.14
Monkeypox: a detailed profile of the disease
Physicians and scientists from the Institut Pasteur, the Pasteur Network and ANRS | Emerging Infectious Diseases have conducted a review of the medical and scientific literature about monkeypox. The review, which paints a complete picture of the disease, was published in the New England Journal of Medicine on October 26, 2022. What are the signs of this disease? Where does it come from? How is it...
-
Événement | 2022.12.07
Colloquium "Epidemics, pandemics: a never-ending story?"
On the occasion of the bicentenary of the birth of Louis Pasteur, the Institut Pasteur is organizing a major conference day, open to everyone, on December 7 from 9 a.m., in the auditorium of the Centre d'information scientifique.Program and registration (in French)The goal of this conference is to analyze the major epidemics that have struck humanity since its origin and to draw lessons to...
-
News | 2022.11.17
Royal Society: looking back at the tribute to Louis Pasteur in London
The Institut Pasteur, the French Academy of Sciences and the Royal Society held a scientific symposium that brought French and British researchers together to celebrate the bicentenary of Louis Pasteur's birth and promote international scientific cooperation.
-
News | 2022.11.10
ERC grants: new funding awarded in October 2022
Since they were launched in 2007, European Research Council (ERC) grants have become a mark of scientific excellence. Three new ERC Synergy Grants have recently been awarded for international projects involving scientists working on the Institut Pasteur campus.
